In agreement with the accumulated evidences on NLGP’s immunomodulation, here, curtain has been raised to show the NLGP mediated CD8+ T cell dependent immunomodulation, which is the key reason of sarcoma growth restriction and increased survivability (3). The gene discussed is CD8A; the disease is sarcoma.